Pricing Table
Kit Size | Dosage per Vial | Total Peptide | Your Price | Price per mg |
---|---|---|---|---|
Single Vial | 5mg | 5mg | $200 | $40.00/mg |
Single Vial | 10mg | 10mg | $210 | $21.00/mg |
Single Vial | 30mg | 30mg | $240 | $8.00/mg |
Single Vial | 60mg | 60mg | $270 | $4.50/mg |
10 Vials | 5mg | 50mg | $230 | $4.60/mg |
10 Vials | 10mg | 100mg | $265 | $2.65/mg |
10 Vials | 15mg | 150mg | $360 | $2.40/mg |
10 Vials | 20mg | 200mg | $420 | $2.10/mg |
10 Vials | 30mg | 300mg | $530 | $1.77/mg |
10 Vials | 40mg | 400mg | $620 | $1.55/mg |
10 Vials | 50mg | 500mg | $680 | $1.36/mg |
10 Vials | 60mg | 600mg | $750 | $1.25/mg |
10 Vials | 100mg | 1000mg | $900 | $0.90/mg |
Quick Product Specs
- Purity: ≥99%
- Form: Lyophilized Powder
- CAS Number: 2023788-19-2
- Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
- Storage: -20°C (freezer)
- Shelf Life: 24 months unopened
- Type: Dual GIP/GLP-1 Receptor Agonist
What is Tirzepatide?
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This innovative peptide represents a breakthrough in incretin-based therapy research, simultaneously activating both GIP and GLP-1 receptors to produce enhanced metabolic effects. Tirzepatide has shown remarkable results in research studies for glucose control, weight reduction, and insulin sensitivity improvement, often surpassing single-agonist peptides in efficacy.
Research Applications
- Dual incretin pathway and synergy research
- Advanced metabolic health investigation
- Weight regulation and appetite control studies
- Insulin sensitivity and beta-cell function research
- Cardiovascular effects and protection analysis
- Energy expenditure mechanism studies
- Comparative incretin therapy research